العربية
Pharmacovigilance:
Reporting Suspected Adverse Reactions
Reporting suspected adverse reactions after authorization of the medicinal product is import
It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via: pvdept@sedicopharma.com
Or via EPVC
Website: www.edaegypt.gov.eg
E-mail: pv.followup@edaegypt.gov.eg
Or by scanning QR code
